Treace Medical Concepts
TMCI
138 hedge funds and large institutions have $315M invested in Treace Medical Concepts in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 46 reducing their positions, and 26 closing their positions.
1,452% more call options, than puts
Call options by funds: $388K | Put options by funds: $25K
14% more capital invested
Capital invested by funds: $278M → $315M (+$37.5M)
12% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 26
2% more funds holding
Funds holding: 135 → 138 (+3)
0.7% more ownership
Funds ownership: 59.88% → 60.58% (+0.7%)
11% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$6.41M |
| 2 |
First Eagle Investment Management
New York
|
+$4.48M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.21M |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$3.64M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.48M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.46M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$1.98M |
| 4 |
Goldman Sachs
New York
|
-$1.84M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.76M |
TMCI Hedge Fund Activity: Q1 2025 in Review
138 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2025, worth a combined $315M — up 14% from $278M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new TMCI positions and 26 closed out — a net gain of 3 holders — while 41 added to existing stakes and 46 trimmed.
The largest buyer was Parkman Healthcare Partners, opening a new position worth an estimated $6.41M. The largest seller was Morgan Stanley, cutting an estimated $5.48M.
- 138 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2025, up from 135 in Q4 2024.
- Funds reported $315M of Treace Medical Concepts stock for Q1 2025, up 14% quarter-over-quarter.
- 29 funds opened new Treace Medical Concepts positions in Q1 2025 and 26 closed out, a net change of +3 holders.
- The largest Treace Medical Concepts buyer in Q1 2025 was Parkman Healthcare Partners, an estimated $6.41M added.
- The largest Treace Medical Concepts seller in Q1 2025 was Morgan Stanley, an estimated $5.48M sold.
Based on aggregated 13F filings for Q1 2025.